S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Seattle GeneticsNOVOZYMES A/S/SNeurocrine BiosciencesQiagenBIO-TECHNE
SymbolNASDAQ:SGENOTCMKTS:NVZMYNASDAQ:NBIXNYSE:QGENNASDAQ:TECH
Price Information
Current Price$100.89$43.07$97.35$28.11$203.44
52 Week RangeBuyHoldBuyHoldBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyHoldBuy
Consensus Price Target$87.92N/A$106.56$34.86$206.80
% Upside from Price Target-12.85% downsideN/A9.46% upside24.00% upside1.65% upside
Trade Information
Market Cap$13.90 billion$12.70 billion$8.87 billion$6.42 billion$7.59 billion
Beta1.950.751.220.851.21
Average Volume927,12423,961805,4511,245,997173,165
Sales & Book Value
Annual Revenue$654.70 million$2.28 billion$451.24 million$1.50 billion$714.01 million
Price / Sales24.925.6119.764.2210.80
CashflowN/A$1.73 per share$0.50 per share$2.45 per share$6.03 per share
Price / CashN/A24.84193.1911.4733.76
Book Value$7.95 per share$6.10 per share$5.30 per share$11.69 per share$30.78 per share
Price / Book12.697.0618.372.406.61
Profitability
Net Income$-222,690,000.00$511 million$21.11 million$190.38 million$96.07 million
EPS($1.65)$1.75$0.22$1.34$3.80
Trailing P/E RatioN/A24.61442.5020.9853.54
Forward P/E RatioN/A26.1028.9718.3738.97
P/E GrowthN/A$2.02$5.97$2.01$4.25
Net Margins-36.94%22.31%2.98%12.94%13.45%
Return on Equity (ROE)-17.16%28.54%0.46%12.10%13.20%
Return on Assets (ROA)-14.39%16.00%0.21%5.76%7.98%
Dividend
Annual PayoutN/A$0.50N/AN/A$1.28
Dividend YieldN/A1.16%N/AN/A0.63%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A28.57%N/AN/A33.68%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.05%0.96%0.54%0.42%
Current Ratio3.03%1.27%7.44%1.77%4.05%
Quick Ratio2.70%0.75%7.32%1.59%3.15%
Ownership Information
Institutional Ownership Percentage98.65%0.18%96.09%62.08%92.14%
Insider Ownership Percentage33.80%N/A4.30%9.00%4.20%
Miscellaneous
Employees1,3026,4275854,9522,250
Shares Outstanding161.72 million297.00 million91.58 million225.51 million37.89 million
Next Earnings Date10/29/2019 (Confirmed)10/23/2019 (Confirmed)11/4/2019 (Confirmed)10/30/2019 (Confirmed)10/29/2019 (Confirmed)
OptionableOptionableNot OptionableOptionableOptionableOptionable
 Seattle GeneticsNOVOZYMES A/S/SNeurocrine BiosciencesQiagenBIO-TECHNE

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel